Montelukast

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Montelukast and local guidelines before prescribing.

Leukotriene receptor antagonist

Mechanism

Cysteinyl leukotriene receptor antagonist.

Uses

Asthma, allergic rhinitis, exercise-induced bronchoconstriction.

Dosing

Side effects

Headache, abdominal pain, neuropsychiatric effects (sleep disturbance, agitation, suicidal thoughts).

Interactions

Phenobarbital reduces levels.

Contraindications and cautions

Phenylketonuria (chewable tablets)

Monitoring

Mood, sleep

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

Caution in hepatic impairment

Overdose and reversal

Supportive

Special advice

MHRA warning on neuropsychiatric effects; review if mood change.

More from the textbook: uses, cautions and other points
Where it is discussed in the book